SCM
WST icon

Sterling Capital Management’s West Pharmaceutical WST Stock Holding History

Sterling Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71M Sell
15,904
-660
-4% -$202K 0.1% 186
2026
Q1 		$4.15M Sell
16,564
-1,984
-11% -$494K 0.08% 205
2025
Q4 		$5.1M Sell
18,548
-1,714
-8% -$469K 0.08% 193
2025
Q3 		$5.32M Buy
20,262
+67
+0.3% +$16.3K 0.08% 172
2025
Q2 		$4.42M Buy
20,195
+3,017
+18% +$645K 0.06% 215
2025
Q1 		$3.85M Sell
17,178
-690
-4% -$190K 0.06% 217
2024
Q4 		$5.85M Buy
17,868
+473
+3% +$149K 0.08% 178
2024
Q3 		$5.22M Buy
+17,395
New +$5.33M 0.07% 209
2019
Q3 		$27.8M Sell
196,173
-25,500
-12% -$3.51M 0.26% 111
2019
Q2 		$27.7M Hold
221,673
– – 0.27% 109
2019
Q1 		$24.4M Sell
221,673
-50,000
-18% -$5.2M 0.24% 121
2018
Q4 		$26.6M Sell
271,673
-65,232
-19% -$7.08M 0.29% 108
2018
Q3 		$41.6M Hold
336,905
– – 0.38% 94
2018
Q2 		$33.5M Hold
336,905
– – 0.31% 96
2018
Q1 		$29.7M Buy
336,905
+39,424
+13% +$3.69M 0.28% 108
2017
Q4 		$29.4M Sell
297,481
-44,979
-13% -$4.41M 0.27% 102
2017
Q3 		$33M Buy
342,460
+15,160
+5% +$1.37M 0.31% 98
2017
Q2 		$30.9M Sell
327,300
-70,000
-18% -$6.44M 0.3% 98
2017
Q1 		$32.4M Sell
397,300
-654
-0.2% -$54.7K 0.31% 98
2016
Q4 		$33.8M Sell
397,954
-37,346
-9% -$2.94M 0.3% 96
2016
Q3 		$32.4M Hold
435,300
– – 0.3% 95
2016
Q2 		$33M Sell
435,300
-117,000
-21% -$8.51M 0.3% 98
2016
Q1 		$38.3M Sell
552,300
-96,000
-15% -$5.78M 0.35% 95
2015
Q4 		$39M Hold
648,300
– – 0.35% 97
2015
Q3 		$35.1M Buy
+648,300
New +$37.8M 0.31% 104

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sterling Capital Management's WST Position: Q2 2026 in Review

Sterling Capital Management reduced its West Pharmaceutical (WST) stake by 4% in Q2 2026, selling an estimated $202K and leaving 15,904 shares worth $5.71M. The position accounts for 0.1% of the portfolio, ranked #186.

Sterling Capital Management first reported a position in WST in Q3 2015 and has held it in 25 quarters since. The position peaked at $41.6M in Q3 2018. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Sterling Capital Management held 15,904 shares of West Pharmaceutical worth $5.71M as of Q2 2026.
  • Sterling Capital Management sold 660 West Pharmaceutical shares in Q2 2026, an estimated $202K.
  • West Pharmaceutical made up 0.1% of Sterling Capital Management's portfolio in Q2 2026, its #186 holding.
  • Sterling Capital Management first reported a position in West Pharmaceutical in Q3 2015 and has held it in 25 quarters since.
  • Sterling Capital Management's West Pharmaceutical position peaked at $41.6M in Q3 2018.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.